1. A validated UPLC–MS/MS method for flibanserin in plasma and its pharmacokinetic interaction with bosentan in rats. (July 2018) Authors: Iqbal, Muzaffar; Ezzeldin, Essam; Rezk, Naser L; Bajrai, Amal A; Al-Rashood, Khalid A Journal: Bioanalysis Issue: Volume 10:Number 14(2018) Page Start: 1087 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Determination of apremilast in rat plasma by UPLC–MS/MS in ESI-negative mode to avoid adduct ions formation. (July 2016) Authors: Iqbal, Muzaffar; Ezzeldin, Essam; Al-Rashood, Sara TA; Imam, Faisal; Al-Rashood, Khalid A Journal: Bioanalysis Issue: Volume 8:Number 14(2016) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Simultaneous Detection and Quantification of Three Novel Prescription Drugs of Abuse (Suvorexant, Lorcaserin and Brivaracetam) in Human Plasma by UPLC–MS-MS. Issue 3 (6th October 2018) Authors: Iqbal, Muzaffar; Khalil, Nasr Y; Ezzeldin, Essam; Al-Rashood, Khalid A Journal: Journal of analytical toxicology Issue: Volume 43:Issue 3(2019) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. UPLC/MS–MS assay development for estimation of mozavaptan in plasma and its pharmacokinetic study in rats. (July 2018) Authors: Ezzeldin, Essam; Mostafa, Gamal AE; Iqbal, Muzaffar; Al-Rashood, Khalid A; Asiri, Yousef; El-Nahhas, Toqa Journal: Bioanalysis Issue: Volume 10:Number 14(2018) Page Start: 1077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗